Update on gene therapy for immunodeficiencies
- 31 May 2010
- journal article
- review article
- Published by Elsevier BV in Clinical Immunology
- Vol. 135 (2), 247-254
- https://doi.org/10.1016/j.clim.2009.12.003
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Mechanisms of double-strand break repair in somatic mammalian cellsBiochemical Journal, 2009
- High-resolution profiling of homing endonuclease binding and catalytic specificity using yeast surface displayNucleic Acids Research, 2009
- Effect of Ex Vivo Culture of CD34+ Bone Marrow Cells on Immune Reconstitution of XSCID Dogs Following Allogeneic Bone Marrow TransplantationTransplantation and Cellular Therapy, 2009
- Transcriptional Enhancers Induce Insertional Gene Deregulation Independently From the Vector Type and DesignMolecular Therapy, 2009
- The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapyJCI Insight, 2009
- Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: Current status and critical needsJournal of Allergy and Clinical Immunology, 2008
- Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patientsJCI Insight, 2008
- Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1JCI Insight, 2008
- Gene therapy improves immune function in preadolescents with X-linked severe combined immunodeficiencyBlood, 2007
- A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined ImmunodeficiencyThe New England Journal of Medicine, 2003